Ipamorelin
Selective Growth Hormone Secretagogue Studied for Pulsatile GH Release
Written by
BioPeptide Research Team
Medical review
Pending medical review
Overview
Ipamorelin is a five-amino-acid synthetic peptide classified as a growth hormone secretagogue (GHS). It is frequently studied alongside GHRH analogues such as CJC-1295, since the two are believed to act on complementary pathways governing the body's natural growth-hormone release cycle.
Proposed Mechanism
Ipamorelin is described in the literature as a selective agonist of the ghrelin / growth-hormone-secretagogue receptor (GHS-R). Research has focused on whether this selectivity allows it to stimulate pituitary growth-hormone release with comparatively minimal impact on cortisol, prolactin, and other hormones — a distinguishing feature researchers have highlighted relative to earlier-generation secretagogues.
Research Highlights
- Early pharmacological studies characterized Ipamorelin's receptor-binding selectivity relative to other growth-hormone secretagogues
- Animal research has examined its pulsatile effect on growth-hormone secretion patterns
- Comparative studies have investigated whether its hormonal-selectivity profile reduces the off-target endocrine effects observed with non-selective secretagogues
Research Dosing Reference
Rodent endocrine studies
Exact values vary significantly by study design and endpoint — acute GH-pulse vs. chronic-dosing models
Microgram-per-kilogram range, subcutaneous, pulsatile schedules
Figures above are reported ranges from published animal/laboratory studies, summarized for academic reference — not recommendations for human or animal administration.
Reported Research Cycle Lengths
Reference guides commonly cite research cycles of roughly 8 to 12 weeks for Ipamorelin, frequently grouped alongside other selective growth-hormone-secretagogue literature.
Durations referenced here reflect ranges commonly cited across compound literature and reference guides — summarized for academic comparison only. They are not usage recommendations for humans or animals, and do not substitute for primary source review.
Reconstitution & Volume Calculator
A unit-conversion utility for laboratory use. It converts a vial strength and reconstitution volume into a draw volume — it performs arithmetic only and does not suggest, recommend, or imply an appropriate amount of Ipamorelin for any purpose.
Concentration
2500.0 mcg/mL
Draw volume
0.100 mL
Syringe reading
10.0 units
For laboratory research reference only — not medical advice, and not a dosing recommendation for human or animal use. "Syringe reading" assumes a standard U-100 (100 units per mL) insulin syringe.
Safety & Compliance Notes
- Ipamorelin is not approved for human therapeutic use by the FDA or equivalent regulatory bodies
- All information here is summarized from laboratory and animal-research literature for educational reference
- Sold strictly as a research chemical — not for human consumption or clinical use
Research Citations
Verified PubMed citations for this compound are being compiled by our medical review team and will appear here once confirmed. In the meantime, search PubMed directly for independent peer-reviewed literature on this compound.
Research Grade · Lab Verified
Browse research-grade Ipamorelin and related compounds in our shop — shipped with a certificate of analysis, sold strictly for research purposes.
This page is provided for educational and research-reference purposes only and does not constitute medical advice, a treatment recommendation, or an endorsement of human use. Always consult primary peer-reviewed literature and a qualified professional before drawing conclusions about any compound. All products referenced are sold strictly for laboratory research — not for human consumption.